Sharmila Chamling Rai, Mph
About Sharmila Chamling Rai, Mph
Sharmila Chamling Rai is a scientist specializing in oncology research, currently working at Bristol Myers Squibb in Cambridge, Massachusetts.
Company
Sharmila Chamling Rai is currently working as a Scientist at Bristol Myers Squibb, located in Cambridge, Massachusetts, United States. Bristol Myers Squibb is recognized for its focus on pharmaceutical research and development, specifically in areas such as oncology, immunology, and cardiovascular diseases. As a Scientist, Sharmila Chamling Rai contributes to ongoing projects and research initiatives aimed at advancing therapeutic solutions and improving patient outcomes.
Title
Sharmila Chamling Rai holds the title of Scientist at Bristol Myers Squibb. In this role, she engages in extensive oncology research with a particular emphasis on immunotherapy. Her responsibilities include conducting experiments, analyzing data, and collaborating with cross-functional teams to drive research projects forward. She also plays a pivotal role in mentoring junior scientists and interns, imparting her expertise and guiding them through their professional development.
Education and Expertise
Sharmila Chamling Rai received her Master of Public Health (MPH) from Boston University, where she studied from 2018 to 2021. Prior to that, she earned a Bachelor's Degree in Biology from Northeastern University, graduating in 2015 after four years of study. Her academic background provided a strong foundation in public health and biological sciences, which she leverages in her specialization in oncology research. She also has substantial expertise in immunotherapy, which she applies in her current and past roles.
Background
Before joining Bristol Myers Squibb, Sharmila Chamling Rai worked at Dana-Farber Cancer Institute as a Senior Research Technician from 2015 to 2020 in the Greater Boston Area. During her tenure, she focused on cancer immunotherapy research, contributing significantly to the development of novel therapeutic approaches now in clinical trials. Her work at Dana-Farber involved lab-based research, data collection, and analysis, all of which have been instrumental in her career progression.
Achievements
Sharmila Chamling Rai has made meaningful contributions to the field of oncology research. She co-authored a research paper on cancer immunotherapy during her time at Dana-Farber Cancer Institute, underscoring her role in advancing this critical area of study. Additionally, she was involved in the development of a novel therapeutic approach that is currently undergoing clinical trials. She has presented her research findings at prestigious conferences, including the American Association for Cancer Research (AACR) annual meeting, further showcasing her contributions to the scientific community.